JP2008538494A5 - - Google Patents

Download PDF

Info

Publication number
JP2008538494A5
JP2008538494A5 JP2008505606A JP2008505606A JP2008538494A5 JP 2008538494 A5 JP2008538494 A5 JP 2008538494A5 JP 2008505606 A JP2008505606 A JP 2008505606A JP 2008505606 A JP2008505606 A JP 2008505606A JP 2008538494 A5 JP2008538494 A5 JP 2008538494A5
Authority
JP
Japan
Prior art keywords
xmrv
acid sequence
individual
seq
mutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008505606A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008538494A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/013167 external-priority patent/WO2006110589A2/en
Publication of JP2008538494A publication Critical patent/JP2008538494A/ja
Publication of JP2008538494A5 publication Critical patent/JP2008538494A5/ja
Pending legal-status Critical Current

Links

JP2008505606A 2005-04-07 2006-04-07 癌と関連するガンマレトロウイルス Pending JP2008538494A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66947305P 2005-04-07 2005-04-07
US75180905P 2005-12-19 2005-12-19
PCT/US2006/013167 WO2006110589A2 (en) 2005-04-07 2006-04-07 Gammaretrovirus associated with cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012217415A Division JP2013046619A (ja) 2005-04-07 2012-09-28 癌と関連するガンマレトロウイルス

Publications (2)

Publication Number Publication Date
JP2008538494A JP2008538494A (ja) 2008-10-30
JP2008538494A5 true JP2008538494A5 (https=) 2009-05-28

Family

ID=37024999

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008505606A Pending JP2008538494A (ja) 2005-04-07 2006-04-07 癌と関連するガンマレトロウイルス
JP2012217415A Pending JP2013046619A (ja) 2005-04-07 2012-09-28 癌と関連するガンマレトロウイルス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012217415A Pending JP2013046619A (ja) 2005-04-07 2012-09-28 癌と関連するガンマレトロウイルス

Country Status (8)

Country Link
US (2) US8263085B2 (https=)
EP (1) EP1882032A2 (https=)
JP (2) JP2008538494A (https=)
AU (1) AU2006235266B2 (https=)
CA (1) CA2603863A1 (https=)
MX (1) MX2007012361A (https=)
NZ (1) NZ562221A (https=)
WO (1) WO2006110589A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006235266B2 (en) 2005-04-07 2010-12-23 The Cleveland Clinic Foundation Gammaretrovirus associated with cancer
CN102112141B (zh) * 2008-07-31 2013-03-06 希格马托制药工业公司 用于预防前列腺癌或减缓前列腺癌发展的组合物
CA2748117A1 (en) * 2008-12-23 2010-07-01 The Cleveland Clinic Foundation Method for detection of xmrv
EP2401406A4 (en) * 2009-02-25 2012-09-19 Cepheid METHODS OF DETECTING LUNG CANCER
WO2010132886A1 (en) * 2009-05-15 2010-11-18 The University Of Utah Research Foundation Compositions and methods relating to xmrv-related diseases and conditions
WO2010148323A2 (en) * 2009-06-18 2010-12-23 Whittemore Peterson Institute For Neuro-Immune Disease Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus
EP2449381A1 (en) * 2009-06-30 2012-05-09 Abbott Laboratories Markers of xmrv infection and uses thereof
WO2011041350A2 (en) * 2009-10-02 2011-04-07 Emory University Xenotropic mulv-related virus (xmrv) compositions and methods of use
WO2011091395A1 (en) * 2010-01-25 2011-07-28 Functional Genetics, Inc. Antibodies for diagnosis and therapeutic treatment of prostate cancer
WO2011092199A1 (en) 2010-01-26 2011-08-04 Institut Gustave Roussy Mutated xmrv env proteins in the immunosuppressive domain
WO2011127174A1 (en) * 2010-04-06 2011-10-13 Whittemore Peterson Institute For Neuro-Immune Disease Strains of xenotropic murine leukemia-related virus and methods for detection thereof
EP2913402B1 (en) * 2010-07-16 2017-10-18 Tocagen Inc. Retrovirus detection
WO2012024518A1 (en) * 2010-08-18 2012-02-23 Abbott Laboratories Molecular detection of xmrv infection
WO2012024513A2 (en) * 2010-08-18 2012-02-23 Abbott Laboratories Molecular detection of xmrv infection
WO2012030856A2 (en) * 2010-08-30 2012-03-08 Gen-Probe Incorporated Compositions, methods and reaction mixtures for the detection of xenotropic murine leukemia virus-related virus
US9107892B2 (en) * 2010-10-28 2015-08-18 University of Pittsburgh—of the Commonwealth System of Higher Education Identification of a novel retrovirus in patients with benign prostatic hyperplasia
GB201019043D0 (en) 2010-11-10 2010-12-22 Protea Biopharma N V Use of 2',5'-oligoadenylate derivative compounds
CA2825522A1 (en) 2011-01-26 2012-08-02 Cepheid Methods of detecting lung cancer
EP2561879A1 (en) 2011-08-23 2013-02-27 Protea Biopharma N.V. Macrophage activating factor for use in the treatment of chronic fatigue syndrome (CFS) and CFS-related diseases and disorders
US20130065222A1 (en) * 2011-08-30 2013-03-14 Gen-Probe Incorporated Compositions, methods and reaction mixtures for the detection of murine leukemia virus-related virus
US20140272993A1 (en) * 2013-03-15 2014-09-18 The Translational Genomics Research Institute Method of sequencing a full microrna profile from cerebrospinal fluid
US20140303025A1 (en) * 2013-03-15 2014-10-09 The Translational Genomics Research Institute Methods for the diagnosis and prognosis of neurodegenerative diseases
KR20170120697A (ko) * 2015-03-10 2017-10-31 가부시키가이샤 시마즈세이사쿠쇼 반응장을 제한한 프로테아제 분해 반응에 의한 항체로부터 펩티드 단편을 얻는 방법
CN114898802B (zh) * 2022-07-14 2022-09-30 臻和(北京)生物科技有限公司 基于血浆游离dna甲基化测序数据的末端序列频率分布特征确定方法、评价方法及装置

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0464533T3 (da) 1990-06-28 1999-04-26 Gen Hospital Corp Fusionsproteiner med immunglobulindele, deres fremstilling og anvendelse
DE60235413D1 (de) * 2001-12-07 2010-04-01 Novartis Vaccines & Diagnostic Bei prostatakrebs hochreguliertes endogenes retrovirus
AU2006235266B2 (en) 2005-04-07 2010-12-23 The Cleveland Clinic Foundation Gammaretrovirus associated with cancer
CA2748117A1 (en) 2008-12-23 2010-07-01 The Cleveland Clinic Foundation Method for detection of xmrv
WO2010148323A2 (en) 2009-06-18 2010-12-23 Whittemore Peterson Institute For Neuro-Immune Disease Diagnosis and treatment of diseases or disorders associated with xenotropic murine leukemia virus
US20110151431A1 (en) 2009-06-18 2011-06-23 Whittemore Peterson Institute For Neuro-Immune Disease Detection of xenotropic murine leukemia virus
EP2449381A1 (en) 2009-06-30 2012-05-09 Abbott Laboratories Markers of xmrv infection and uses thereof

Similar Documents

Publication Publication Date Title
JP2008538494A5 (https=)
Yoo et al. Comprehensive analysis of the transcriptional and mutational landscape of follicular and papillary thyroid cancers
KR102622307B1 (ko) 후성유전적 염색체 상호작용
Yu et al. Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration
CN103468813B (zh) Eml4-alk融合基因荧光定量pcr检测试剂盒
JP2007506426A5 (https=)
AU2009240021B2 (en) Antiviral therapy
JP2008249727A5 (https=)
JP2019528063A5 (https=)
JP2012526554A5 (https=)
Kano et al. The presence, persistence and functional properties of Plasmodium vivax duffy binding protein II antibodies are influenced by HLA class II allelic variants
RU2012148125A (ru) Биомаркеры на основе мультиракового ассоциированного с инвазией механизма
US10724097B2 (en) Methods and compositions for diagnosis and management of diabetes and metabolic syndrome
JP2012512389A5 (https=)
JP6387001B2 (ja) Ｃｄｋ阻害剤と関連するバイオマーカー
CN106544342A (zh) Mt2a基因组蛋白乙酰化修饰检测试剂盒及引物对
JP2010502192A5 (https=)
CN114875144B (zh) 用于评估肿瘤ibc疗法的疗效的生物标志物、系统、方法及试剂盒
KR20170055435A (ko) 항암 치료 내성 판단 방법 및 상기 방법에 사용되는 조성물
WO2019173712A1 (en) Addressing treatments for glioblastoma
Zhang et al. Long Non‐Coding RNA IGFRIL Couples with PTBP1 to Destabilize IGFBP3 mRNA to Promote the IGF1R‐AKT‐mTOR Axis and Hepatocellular Carcinoma
JP6949315B2 (ja) 肺扁平上皮癌と肺腺癌の鑑別評価方法
CN109402256B (zh) 利用多个免疫调控点分子的表达量评价胶质瘤临床预后的系统
Sombekke et al. Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis
TWI579722B (zh) 藥物不良反應風險評估方法及其裝置